EndoTic ? Endothelium and Ticagrelor: Pharmacological effects beyond antiplatelet effect - ENDOTIC

Fundación Investigación Sanitaria en León0 个研究点开始时间: 2014年2月4日最近更新: 2016年10月17日

适应症

试验速览

暂无简介。

•1.Provision of informed consent prior to any study specific procedures
•2.Patients older than 18 years.
•3.Males; postmenopausal women or under contraceptive treatment.
•4.Clinical diagnosis of ACS + Elevation of myocardial damage diagnostic biomarkers, using the 3rd universal definition of myocardial infarction31
•5.Planned early invasive strategy, coronary angiography <72 hours after admission
•Are the trial subjects under 18? no
•Number of subjects for this age range:
•F.1.2 Adults (18-64 years) yes
•F.1.2.1 Number of subjects for this age range 60
•F.1.3 Elderly (>=65 years) yes
•F.1.3.1 Number of subjects for this age range 40

•1.Allergy or contraindication to aspirin, clopidogrel or ticagrelor.
•2.Bleeding diathesis or very high risk of bleeding.
•3.Participation in another study that has not reached the programmed follow-up.
•4.Current treatment with oral anticoagulants, thienopyridines or ticagrelor.
•5.Limited life expectancy.
•6.Planned elective surgery.
•7.Failure for completing the study

发起方

Fundación Investigación Sanitaria en León